Bevacizumab for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
AuthID
P-002-SZN
P-002-SZN
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service